RCUS
Arcus Biosciences, Inc. · Healthcare
Chief Accounting Officer Alexander Azoy sold $49K of Arcus Biosciences, Inc.
Sold$49,400
$26.00Price
1,900Shares
−6%Stake
What RCUS did after the filing
- The stock from Mon, Dec 1 close, $26.10
- −5.9%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Jan 14 close.
Traded Wed, Nov 26. Filed Mon, Dec 1, 1:09 PM ET, during the session. Returns use the Dec 1 close and the Jan 14 close. Not investment advice.